Physician profile
Tim Eugene Adamson
NPI 1326046236
$469,993.77
in general payments reported to CMS, 2019-2025
7 companies · $36K in 2025
The $36K reported for 2025 was more than what 93% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83K · 2020: $61K · 2021: $67K · 2022: $78K · 2023: $76K · 2024: $70K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $171K · Consulting Fee: $8,000 · Food and Beverage: $1,738 · Travel and Lodging: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $171,202.00 |
| Consulting Fee | $8,000.00 |
| Food and Beverage | $1,737.67 |
| Travel and Lodging | $1,004.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spine Wave, INC. | $458,608.55 | 2019-2025 | Salvo Spine System, Sniper Spine System, Spinal Implant |
| Arthrex, INC. | $10,421.70 | 2019-2024 | |
| Peerless Surgical INC. | $740.56 | 2024 | |
| Stryker Corporation | $159.07 | 2022 | |
| Aesculap, INC. | $37.74 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $15.15 | 2019 | |
| Medtronic USA, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Adamson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.